非大面积中心性与非中心性肺栓塞的临床预后:一项基于注册登记的队列研究
本研究基于RIETE注册登记,纳入6674例经CT确诊的症状性非大面积肺栓塞患者,比较中心性PE(主肺动脉,占40.5%)与非中心性PE(更外周动脉)在抗凝期间及停用抗凝后复发VTE、大出血和死亡的风险。抗凝期间两组复发VTE风险相似(每100患者年2.5 vs 2.1;aHR 1.32;95%CI 0.91-1.90),大出血和死亡风险亦相似。停用抗凝后,中心性PE组复发VTE风险边缘性高于非中心性PE组(每100患者年11.0 vs 8.0;aHR 1.34;95%CI 1.01-1.78),但限制于特发性PE后该关联不存在(13.8 vs 11.9;aHR 1.15;95%CI 0.79-1.68;P=.48),大出血和死亡风险相似。作者认为该关联幅度小且特发性PE后无关联,临床相关性有限,非大面积特发性PE后抗凝疗程不应根据PE定位调整。
要点
- 非大面积PE中,抗凝期间中心性与非中心性PE的复发VTE风险相似(每100患者年2.5 vs 2.1;aHR 1.32;95%CI 0.91-1.90)。
- 停用抗凝后,中心性PE组复发VTE风险边缘性高于非中心性PE组(每100患者年11.0 vs 8.0;aHR 1.34;95%CI 1.01-1.78)。
- 特发性PE后,中心性与非中心性PE的复发VTE风险无显著差异(每100患者年13.8 vs 11.9;aHR 1.15;95%CI 0.79-1.68;P=.48)。
- 抗凝期间及停用后,两组大出血和死亡风险均相似。
- 作者认为中心性定位与停用抗凝后复发VTE的关联幅度小,临床相关性有限,非大面积特发性PE后抗凝疗程不应根据PE定位调整。
适用人群与场景
- RIETE注册登记中经CT确诊的症状性非大面积肺栓塞患者,共6674例,其中中心性PE(主肺动脉)占40.5%。
- 中心性PE组平均年龄66岁,男性占46.9%,特发性PE占45.0%,癌症相关PE占22.3%,与非中心性PE组相似。
研究设计与关键结果
- 研究类型为基于注册登记的队列研究,样本量6674例,人群为经CT确诊的症状性非大面积PE患者,比较中心性PE(主肺动脉)与非中心性PE(更外周动脉)。
- 抗凝期间(5256.1患者年),复发VTE风险两组相似(每100患者年2.5 vs 2.1;aHR 1.32;95%CI 0.91-1.90),大出血和死亡风险亦相似。
- 停用抗凝后(2175.4患者年),中心性PE组复发VTE风险边缘性高于非中心性PE组(每100患者年11.0 vs 8.0;aHR 1.34;95%CI 1.01-1.78)。
- 限制于特发性PE后,中心性与非中心性PE的复发VTE风险无显著差异(每100患者年13.8 vs 11.9;aHR 1.15;95%CI 0.79-1.68;P=.48)。
- 停用抗凝后,两组大出血和死亡风险相似。
证据类型、等级与局限
- 证据类型:基于注册登记的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,非大面积PE中中心性定位与停用抗凝后复发VTE风险的关联幅度小,且特发性PE后无关联,该发现的临床相关性有限。
- 作者认为,非大面积特发性PE后抗凝疗程不应根据PE定位来调整。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Whether the localization of nonmassive pulmonary embolism (PE) is associated with the short-term and long-term prognosis of patients remains unknown. Our aim was to characterize associations of nonmassive PE localization with risks of recurrent VTE, major bleeding, and mortality during and after anticoagulation.
METHODS: Among participants of the Registro Informatizado de la Enfermedad ThromboEmbòlica (RIETE) registry with incident symptomatic nonmassive PE diagnosed by CT scan, we compared risks of recurrent VTE, major bleeding, and mortality during and after anticoagulation between central PE (main pulmonary artery) and noncentral PE (more peripheral arteries) using Cox proportional hazard-adjusted models.
RESULTS: Of the 6,674 participants, patients with central PE (40.5%) had age (mean 66 years), sex (46.9% male sex), and proportion of idiopathic (45.0%) and cancer-related (22.3%) PE that were similar to those of patients with noncentral PE. During anticoagulation (5,256.1 patient-years), the risk of recurrent VTE was similar between the two groups (2.5 vs 2.1 per 100 patient-years; adjusted hazard ratio [aHR], 1.32; 95% CI, 0.91-1.90), as were risks of major bleeding and mortality. After anticoagulation was discontinued (2,175.4 patient-years), participants with central PE had a borderline greater risk of recurrent VTE than did participants with noncentral PE (11.0 vs 8.0 per 100 patient-years; aHR, 1.34; 95% CI, 1.01-1.78) but not when restricted to participants after unprovoked PE (13.8 vs 11.9 per 100 patient-years; aHR, 1.15; 95% CI, 0.79-1.68; P = .48). Risks of major bleeding and mortality were similar.
CONCLUSIONS: In nonmassive PE, central localization of PE is associated with greater risk of recurrent VTE after anticoagulation cessation. However, the low magnitude of this association and the absence of association after unprovoked PE suggest that the clinical relevance of this finding is limited and that the duration of anticoagulation should not be tailored to PE localization after nonmassive unprovoked PE.
参考来源
- Gouin B, Blondon M, Jiménez D, et al. Clinical Prognosis of Nonmassive Central and Noncentral Pulmonary Embolism: A Registry-Based Cohort Study. Chest. 2016. PMID: 27876590. doi:10.1016/j.chest.2016.10.056
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。